Our experiments demonstrated that IFNγ-pretreated primary human KCs were indeed able to activate even naive T cells by providing costimulatory signals via CD58/CD2 and CD54/LFA-1 interactions. The gene discussed is CD58; the disease is dry eye syndrome.